Healthcare sector news highlights include Novo Nordisk rebranding to 'Novo' to compete with Eli Lilly in the obesity market. Summit Therapeutics reported ivonescimab reduced lung cancer death risk by 27% versus Keytruda. GE HealthCare is nearing a $1B acquisition of Sofie Biosciences. Eli Lilly received full FDA approval for its Inluriyo combo in breast cancer, while Medtronic launched an exchange offer to separate its MiniMed diabetes business.
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Read Original